Follow
Tomas Kalincik
Tomas Kalincik
Professor of Neurology, University of Melbourne and Royal Melbourne Hospital
Verified email at unimelb.edu.au - Homepage
Title
Cited by
Cited by
Year
Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis
JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ...
Jama 321 (2), 175-187, 2019
4512019
Defining secondary progressive multiple sclerosis
J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ...
Brain 139 (9), 2395-2405, 2016
3872016
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
A He, B Merkel, JWL Brown, LZ Ryerson, I Kister, CB Malpas, S Sharmin, ...
The Lancet Neurology 19 (4), 307-316, 2020
2832020
Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis
S Simpson-Yap, E De Brouwer, T Kalincik, N Rijke, JA Hillert, C Walton, ...
Neurology 97 (19), e1870-e1885, 2021
2102021
Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis
VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ...
Annals of neurology 80 (1), 89-100, 2016
2042016
Defining reliable disability outcomes in multiple sclerosis
T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ...
Brain 138 (11), 3287-3298, 2015
1992015
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis
T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ...
Brain 136 (12), 3609-3617, 2013
1932013
Thalamic atrophy is associated with development of clinically definite multiple sclerosis
R Zivadinov, E Havrdová, N Bergsland, M Tyblova, J Hagemeier, Z Seidl, ...
Radiology 268 (3), 831-841, 2013
1912013
Multiple sclerosis relapses: epidemiology, outcomes and management. A systematic review
T Kalincik
Neuroepidemiology 44 (4), 199-214, 2015
1882015
Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis
T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ...
Annals of Neurology 77 (3), 425-435, 2015
1852015
Treatment decisions in multiple sclerosis—insights from real-world observational studies
M Trojano, M Tintore, X Montalban, J Hillert, T Kalincik, P Iaffaldano, ...
Nature Reviews Neurology 13 (2), 105-118, 2017
1792017
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
T Kalincik, JWL Brown, N Robertson, M Willis, N Scolding, CM Rice, ...
The Lancet Neurology 16 (4), 271-281, 2017
1702017
Fingolimod after natalizumab and the risk of short-term relapse
VG Jokubaitis, V Li, T Kalincik, G Izquierdo, S Hodgkinson, R Alroughani, ...
Neurology 82 (14), 1204-1211, 2014
1552014
Cross cultural validation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) and the brief international cognitive assessment for multiple …
JB Dusankova, T Kalincik, E Havrdova, RHB Benedict
The Clinical Neuropsychologist 26 (7), 1186-1200, 2012
1542012
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis
D Ontaneda, E Tallantyre, T Kalincik, SM Planchon, N Evangelou
The Lancet Neurology 18 (10), 973-980, 2019
1422019
Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: a systematic review
B Merkel, H Butzkueven, AL Traboulsee, E Havrdova, T Kalincik
Autoimmunity reviews 16 (6), 658-665, 2017
1412017
Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis
A He, T Spelman, V Jokubaitis, E Havrdova, D Horakova, M Trojano, ...
JAMA neurology 72 (4), 405-413, 2015
1282015
Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years
R Zivadinov, N Bergsland, O Dolezal, S Hussein, Z Seidl, MG Dwyer, ...
American Journal of Neuroradiology 34 (10), 1931-1939, 2013
1222013
Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study
T Kalincik, M Vaneckova, M Tyblova, J Krasensky, Z Seidl, E Havrdova, ...
PloS one 7 (11), e50101, 2012
1162012
Clinical correlates of grey matter pathology in multiple sclerosis
D Horakova, T Kalincik, J Blahova Dusankova, O Dolezal
BMC neurology 12, 1-10, 2012
1142012
The system can't perform the operation now. Try again later.
Articles 1–20